Aardvark Therapeutics (AARD) Earnings Date & Reports

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AARD is expected to report earnings to rise 16.67% to -76 cents per share on December 03

Aardvark Therapeutics AARD Stock Earnings Reports

Q3'25

Est.

$-0.77

Q2'25

Beat

by $0.04

The last earnings report on August 13 showed earnings per share of -66 cents, beating the estimate of -69 cents. With 10.25K shares outstanding, the current market capitalization sits at 274.85M.

View a ticker or compare two or three

Compare

AARD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AARD
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AARD showed earnings on August 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details